Alan Mendelsohn - Apr 15, 2023 Form 4 Insider Report for Timber Pharmaceuticals, Inc. (TMBR)

Role
EVP & CMO
Signature
/s/ Joseph Lucchese, Power of Attorney
Stock symbol
TMBR
Transactions as of
Apr 15, 2023
Transactions value $
$0
Form type
4
Date filed
4/18/2023, 11:40 AM
Previous filing
Apr 19, 2022
Next filing
Aug 22, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMBR Stock Option (right to buy) Award $0 +22.5K $0.00 22.5K Apr 15, 2023 Common Stock 22.5K $1.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the options vest on April 15, 2024, and the remaining shares will become exercisable in 36 equal monthly installments beginning on May 15, 2024, as long as the Reporting Person remains in continuous service with Timber Pharmaceuticals, Inc. through each vesting date.